Is tezepelumab more than just an anti-eosinophil drug?
Eur Respir J
.
2021 Dec 31;59(1):2101700.
doi: 10.1183/13993003.01700-2021.
Print 2022 Jan.
Authors
Adil Adatia
1
2
,
Mustafaa Wahab
1
,
Imran Satia
3
2
Affiliations
1
McMaster University, Dept of Medicine, Hamilton, ON, Canada.
2
Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada.
3
McMaster University, Dept of Medicine, Hamilton, ON, Canada satiai@mcmaster.ca.
PMID:
34972684
DOI:
10.1183/13993003.01700-2021
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Asthmatic Agents*
Antibodies, Monoclonal, Humanized
Eosinophils
Humans
Pharmaceutical Preparations*
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Pharmaceutical Preparations
tezepelumab